Beth Carella, D.O.

  • Assistant Professor of Pediatrics

Seminars

  • “HLA-typing, Part 1,” oral presentation, Hematology/Oncology Fellow Lecture Series, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA., February 2017
  • “HLA-typing, Part 2,” oral presentation, Hematology/Oncology Fellow Lecture Series, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA., June 2017

Professional Affilitations/Society Memberships

  • American Society of Pediatric Hematology/Oncology
  • American Society of Blood and Marrow Transplant
  • American Society of Hematology
  • Children’s Oncology Group
  • American Academy of Pediatrics

Education & Training

  • DO: Touro University College of Osteopathic Medicine Vallejo, CA
  • Residency: University of Connecticut, Connecticut Children's Hartford, CT
  • Fellowship: New York University School of Medicine New York, NY
  • Fellowship: Memorial Sloan-Kettering Cancer Center New York, NY

Research Interests

Carella’s clinical research focused on expanding utilization of stem cell transplant for patients with sickle cell disease. Collaborating with Szabolcs, she continued developing a clinical trial to broaden opportunities for patients lacking matched sibling donors (~82% African-American population). When using mismatched donors, the risk of GVHD is high, however, this protocol will use in-vitro T-cell depletion to reduce risks. This approach will allow a larger number of severely affected patients access to a curative intervention. Combined with a reduced-intensity conditioning regimen, the trial aims to allow for successful engraftment while reducing toxicity for this non-malignant disease. She was the institutional principal investigator for the BMTCTN STRIDE II protocol, which compared the standard of care to myeloablative, matched transplantation for patients with sickle cell disease. She was the institutional principal investigator for the PBMTC SUP1601 protocol, which aimed to identify pathogens in SCT patients with lower respiratory tract infections.

Major Lectureships and Seminars

  • “HLA Typing, Part 1,” oral presentation, Hematology/ Oncology Fellow Lecture Series, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pa., February 2017
  • “HLA Typing, Part 2,” oral presentation, Hematology/ Oncology Fellow Lecture Series, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pa., June 2017

Advisory Committee Memberships

  • University of Pittsburgh IRB, June 2017

Professional Affiliations/Society Memberships

  • American Society of Pediatric Hematology/Oncology
  • American Society of Blood and Marrow Transplant
  • American Society of Hematology
  • Children’s Oncology Group
  • American Academy of Pediatrics

Division